The deal marks a major step in H.B. Fuller’s push into medical adhesives and biosurgical technologies
The product combines high-purity DIB with butylated hydroxytoluene, a widely used antioxidant that helps limit oxidation during storage and maintain product integrity over time
The carbon-fiber-reinforced, impact-modified material is now proving its value in real-world emergency operations, including use by BASF’s plant fire brigade
The company now expects adjusted EBITDA of €2.0 billion to €2.2 billion, compared with its previous guidance of €1.7 billion to €2.0 billion
The venture is expected to create a significant new platform for the production of high-purity solvents
The system connects shared regional storage and logistics infrastructure directly to Evonik’s production site
The approval brings one of the world’s most widely used modern UV filters into the American market for the first time
This joint venture advances SI Group’s growth strategy and strengthens our ability to serve customers in key markets around the world
Increases midpoint of full-year adjusted EBITDA and adjusted EPS guidance
The launch also marks the introduction of BASF Aroma Ingredients’ new innovation concept based on Safe-by-Design principles
The company said the investments will expand its specialty silicones footprint across the United States, China and Japan
The company said it will retain ownership of adjacent Maryland properties and emphasized that the deal is intended to optimize its asset base
The acquisition is set to deepen Brewer Science’s advanced materials portfolio
ClarityChem brings more than 30 years of experience delivering water treatment programs for boilers, cooling systems, biocides, closed-loop systems, wastewater treatment, and odor control
The industry is also grappling with high energy costs and carbon taxation in Europe, expenses that many international competitors do not face
The closure comes as the company moves to streamline its manufacturing network in response to ongoing industry challenges, including oversupply and weak margins
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
The company says demand is being driven by global megatrends— electromobility, renewable energy, grid expansion, digitalization, and medical innovation
Chemically known as flufenoxadiazam, Adapzo Active is the first-ever histone deacetylase (HDAC) inhibitor in the industry
Decades of investment in feedstock diversity, gasifier infrastructure, and operational discipline paid off when global systems came under strain
Subscribe to our newsletter & stay updated.
